Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection-Import/Export Declaration for List I and List II Chemicals, DEA Forms 486, 486A, 38218-38219 [2016-13908]
Download as PDF
38218
Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices
Controlled substance
Schedule
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) ..................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
Psilocybin (7437) .........................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine (7439) ..............................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ...............................................................................................................................................
N-Benzylpiperazine (7493) ..........................................................................................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) (7535) .......................................................................................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) (7540) .......................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Norlevorphanol (9634) .................................................................................................................................................................................
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Nabilone (7379) ...........................................................................................................................................................................................
1-Phenylcyclohexylamine (7460) .................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Cocaine (9041) ............................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Ecgonine (9180) ..........................................................................................................................................................................................
Levomethorphan (9210) ..............................................................................................................................................................................
Levorphanol (9220) .....................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Metazocine (9240) .......................................................................................................................................................................................
Methadone (9250) .......................................................................................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Thebaine (9333) ..........................................................................................................................................................................................
Levo-alphacetylmethadol (9648) .................................................................................................................................................................
Remifentanil (9739) .....................................................................................................................................................................................
Sufentanil (9740) .........................................................................................................................................................................................
Carfentanil (9743) ........................................................................................................................................................................................
Fentanyl (9801) ...........................................................................................................................................................................................
The company plans to manufacture
reference standards.
Comments are encouraged and
will be accepted for 60 days until
August 12, 2016.
DATES:
Dated: June 7, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Clifton A. Coward, Jr., Office of
Diversion Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2016–13914 Filed 6–10–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0023]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection—Import/Export
Declaration for List I and List II
Chemicals, DEA Forms 486, 486A
Drug Enforcement
Administration, Department of Justice
ACTION: 60-Day notice.
srobinson on DSK5SPTVN1PROD with NOTICES
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
SUMMARY:
VerDate Sep<11>2014
20:48 Jun 10, 2016
Jkt 238001
Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Import/Export Declaration for List I and
List II Chemicals.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Forms: 486, 486A. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Office of Diversion
Control.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
E:\FR\FM\13JNN1.SGM
13JNN1
38219
Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices
Affected public (Other): Not-for-profit
institutions; Federal, State, local, and
tribal governments.
Abstract: Section 1018 of the
Controlled Substances Import and
Export Act (CSIEA) (21 U.S.C. 971) and
Title 21 Code of Federal Regulations (21
CFR) Part 1313 require any persons who
import, export, or conduct international
transactions involving list I and list II
chemicals are required to establish a
system of recordkeeping and report
certain information regarding those
transactions to the DEA. The chemicals
subject to control are used in the
clandestine manufacture of controlled
substances.
Number of
annual
respondents *
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The below table presents
information regarding the number of
respondents, responses and associated
burden hours.
Number of
annual
responses
Average
time per
response
(minutes)
Total annual
hours
DEA–486—Import (paper) ...............................................................................
DEA–486—Import (online) ...............................................................................
DEA–486—Export (paper) ...............................................................................
DEA–486—Export (online) ..............................................................................
DEA–486—International (paper) .....................................................................
DEA–486A—Import (paper) .............................................................................
DEA–486A—Import (online) ............................................................................
342
........................
........................
........................
........................
........................
........................
1,359
855
2,533
7,743
422
333
416
17
17
20
20
17
20
20
385
242
844
2,581
120
111
139
Total ..........................................................................................................
342
13,661
........................
4,422
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: The DEA estimates
that this collection takes 4,442 annual
burden hours.
If additional information is required
please contact: Jerri Murray,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Suite 3E.405B,
Washington, DC 20530.
Dated: June 8, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2016–13908 Filed 6–10–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0009]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection Controlled
Substances Import/Export Declaration
DEA Form 236
Drug Enforcement
Administration, Department of Justice
ACTION: 60-Day notice.
srobinson on DSK5SPTVN1PROD with NOTICES
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
SUMMARY:
VerDate Sep<11>2014
20:48 Jun 10, 2016
Jkt 238001
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
August 12, 2016.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Clifton A. Coward, Jr., Office of
Diversion Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Controlled Substances Import/Export
Declaration (DEA Form 236).
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form Number: DEA Form 236. The
Department of Justice component is the
Drug Enforcement Administration,
Office of Diversion Control.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): None.
Abstract: DEA Form 236 enables the
DEA to monitor and control the
importation and exportation of
controlled substances. Analysis of these
documents provides the DEA with
important intelligence regarding the
international commerce in controlled
substances and assists in the
identification of suspected points of
diversion.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates that there
are 157 total respondents for this
information collection. In total, 157
respondents submit 6,321 responses,
with each response taking 17 minutes to
complete.
E:\FR\FM\13JNN1.SGM
13JNN1
Agencies
[Federal Register Volume 81, Number 113 (Monday, June 13, 2016)]
[Notices]
[Pages 38218-38219]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13908]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-0023]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; Extension Without Change of a Previously Approved
Collection--Import/Export Declaration for List I and List II Chemicals,
DEA Forms 486, 486A
AGENCY: Drug Enforcement Administration, Department of Justice
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995.
DATES: Comments are encouraged and will be accepted for 60 days until
August 12, 2016.
FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated
public burden or associated response time, suggestions, or need a copy
of the proposed information collection instrument with instructions or
additional information, please contact Clifton A. Coward, Jr., Office
of Diversion Control, Drug Enforcement Administration; Mailing Address:
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202)
598-6812.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other forms of information technology, e.g.,
permitting electronic submission of responses.
Overview of This Information Collection
1. Type of Information Collection: Extension of a currently
approved collection.
2. Title of the Form/Collection: Import/Export Declaration for List
I and List II Chemicals.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: DEA Forms: 486, 486A. The
applicable component within the Department of Justice is the Drug
Enforcement Administration, Office of Diversion Control.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
[[Page 38219]]
Affected public (Other): Not-for-profit institutions; Federal,
State, local, and tribal governments.
Abstract: Section 1018 of the Controlled Substances Import and
Export Act (CSIEA) (21 U.S.C. 971) and Title 21 Code of Federal
Regulations (21 CFR) Part 1313 require any persons who import, export,
or conduct international transactions involving list I and list II
chemicals are required to establish a system of recordkeeping and
report certain information regarding those transactions to the DEA. The
chemicals subject to control are used in the clandestine manufacture of
controlled substances.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The below table
presents information regarding the number of respondents, responses and
associated burden hours.
----------------------------------------------------------------------------------------------------------------
Number of Number of Average time
annual annual per response Total annual
respondents * responses (minutes) hours
----------------------------------------------------------------------------------------------------------------
DEA-486--Import (paper)......................... 342 1,359 17 385
DEA-486--Import (online)........................ .............. 855 17 242
DEA-486--Export (paper)......................... .............. 2,533 20 844
DEA-486--Export (online)........................ .............. 7,743 20 2,581
DEA-486--International (paper).................. .............. 422 17 120
DEA-486A--Import (paper)........................ .............. 333 20 111
DEA-486A--Import (online)....................... .............. 416 20 139
---------------------------------------------------------------
Total....................................... 342 13,661 .............. 4,422
----------------------------------------------------------------------------------------------------------------
6. An estimate of the total public burden (in hours) associated
with the proposed collection: The DEA estimates that this collection
takes 4,442 annual burden hours.
If additional information is required please contact: Jerri Murray,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC
20530.
Dated: June 8, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2016-13908 Filed 6-10-16; 8:45 am]
BILLING CODE 4410-09-P